Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12620000475943
Ethics application status
Approved
Date submitted
16/03/2020
Date registered
15/04/2020
Date last updated
7/02/2023
Date data sharing statement initially provided
15/04/2020
Type of registration
Prospectively registered

Titles & IDs
Public title
Comparative assessment of treatment efficiency and patient experience between Dental Monitoring and conventional monitoring of clear aligner therapy: A single-center randomized controlled trial
Scientific title
Comparative assessment of treatment efficiency and patient experience between Dental Monitoring and conventional monitoring of clear aligner therapy: A single-center randomized controlled trial
Secondary ID [1] 300721 0
None
Universal Trial Number (UTN)
U1111-1249-2766
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Dental malocclusion. 316555 0
Condition category
Condition code
Oral and Gastrointestinal 314793 314793 0 0
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Each eligible patient was randomly allocated to either a group remotely monitored with DM GoLive or a group monitored conventionally via regularly scheduled clinical visits. All patients were treated with the Invisalign appliance (Align Technology, San Jose, Calif). They were instructed to wear their aligners for a minimum of 22 hours per day. The study followed all participants to completion of orthodontic treatment.

Participants in Dental Monitoring (DM) group were required to take a DM scan at 1-week intervals using the DM app on their smartphones and a ScanBox (a proprietary mouth retractor and positioning device). The DM scan consists of a series of calibrated photos based on instructions provided via the DM app. The photos are processed by DM patented artificial intelligence algorithms that crop the photos, segment the teeth, and conduct a number of clinical observations. The treating investigator (PM) was able to remotely monitor patients’ treatment progress via the Doctor Dashboard and provide patients with appropriate clinical instructions via the DM app’s instant messaging (IM) service to manage non-tracking issues or organise an in-person appointment if clinical intervention was required. DM subjects only attended clinical appointments as required. All DM patients were on the same aligner progression protocol based upon those used by an experienced DM practitioner. Patients were notified via the DM app that they could progress to the next aligner with a “Go” notification or to continue wearing the current aligner with a “No Go” notification. For a “slight unseat” or “slight unseat still present” notification, there was a silent alert and the patient continued with aligner treatment as normal. For a “noticeable unseat” there was a patient warning, and a message was sent to the patient prompting the continued use of chewies. For a “noticeable unseat still present”, there was a patient red alert, and a message was sent to the patient prompting improvement in aligner wear to 22 hours per day. If the DM app informed the patient of a “No Go”, the treating investigator was notified via the cloud-based DM Doctor Dashboard, and a clinical decision was made to “force go”, exclude teeth within the protocol, or schedule a clinical appointment for appropriate intervention. After a “No Go” patients were asked to re-scan after 3 days.
Intervention code [1] 317053 0
Treatment: Other
Comparator / control treatment
The Conventional Monitoring (CM) control group consisted of patients undergoing CAT, whose treatment was monitored by regularly scheduled clinical appointments at 8-week intervals. Each clinical appointment was scheduled for 15min. The CM group were instructed to wear each aligner for 1 week, before progressing to the next aligner. Tracking problems were managed at clinical appointments. The management protocol of poor fitting aligners for the CM group was similar to the DM group. Chewies were prescribed for slightly unseated aligners, and a clinical decision to prolong aligner wear intervals or to recover later with refinement aligners was made by the treating investigator for noticeably unseated aligners.
Control group
Active

Outcomes
Primary outcome [1] 323151 0
The primary outcome of the study was the number of clinical appointments required during overall treatment period.
Timepoint [1] 323151 0
Timepoint: end of clear aligner treatment
Secondary outcome [1] 380962 0
The secondary outcomes were the time taken to reach first refinement, the number of refinements, the total number of aligners, and the overall treatment duration recorded. The number of appointments and number of refinements were considered as count data. The time taken to reach first refinement, total number of aligners and overall treatment duration were considered as continuous quantitative data.
Timepoint [1] 380962 0
Timepoint: end of clear aligner treatment

Eligibility
Key inclusion criteria
Participants were included if they had (1) a full permanent dentition with erupted or erupting second molars, (2) no missing or previously extracted permanent teeth, (3) undergoing comprehensive orthodontic treatment with CAT and (4) did not require premolar extractions or (5) auxiliary appliances as part of orthodontic treatment.
Minimum age
12 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
- Orthodontic treatment requiring premolar extractions
- Active periodontal disease
- High caries risk

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
The numbers were placed in sealed opaque envelopes and shuffled by a clinical assistant. During the clinical appointment where the initial set of aligners were given to participants, the envelopes were opened for group assignment and routine instructions were provided in a closed consultation room to ensure that the treating investigator was blinded.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Randomization was performed using 7 permutated blocks of 8 randomly generated numbers with the random generation function in Excel (Microsoft, Redmond, Wash).
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
1/05/2020
Actual
27/04/2020
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
56
Accrual to date
23
Final
Recruitment in Australia
Recruitment state(s)
QLD

Funding & Sponsors
Funding source category [1] 305167 0
University
Name [1] 305167 0
School of Dentistry, University of Queensland
Country [1] 305167 0
Australia
Primary sponsor type
Individual
Name
Jonathan Lam
Address
School of Dentistry, University of Queensland
288 Herston Road
Herston, QLD 4006
Country
Australia
Secondary sponsor category [1] 305529 0
University
Name [1] 305529 0
School of Dentistry, University of Queensland
Address [1] 305529 0
288 Herston Road
Herston, QLD 4006
Country [1] 305529 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 305532 0
The University of Queensland Human Research Ethics Committee
Ethics committee address [1] 305532 0
Ethics committee country [1] 305532 0
Australia
Date submitted for ethics approval [1] 305532 0
23/03/2020
Approval date [1] 305532 0
14/04/2020
Ethics approval number [1] 305532 0
Ethics approval has been obtained.

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 100694 0
Dr Jonathan Lam
Address 100694 0
School of Dentistry, The University of Queensland
288 Herston Rd
Herston QLD 4006
Country 100694 0
Australia
Phone 100694 0
+61 424542890
Fax 100694 0
Email 100694 0
[email protected]
Contact person for public queries
Name 100695 0
Jonathan Lam
Address 100695 0
School of Dentistry, The University of Queensland
288 Herston Rd
Herston QLD 4006
Country 100695 0
Australia
Phone 100695 0
+61 424542890
Fax 100695 0
Email 100695 0
[email protected]
Contact person for scientific queries
Name 100696 0
Jonathan Lam
Address 100696 0
School of Dentistry, The University of Queensland
288 Herston Rd
Herston QLD 4006
Country 100696 0
Australia
Phone 100696 0
+61 424542890
Fax 100696 0
Email 100696 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.